Hormonal stimulation for in vitro fertilization: A comparison of fertilization rates and cytogenetic findings in unfertilized oocytes

  • P. De Sutter
  • M. Dhont
  • D. Vandekerckhove
Reproductive Genetics


The purpose of this study was to compare fertilization and aneuploidy rates after two stimulation protocols in an IVF program.


This was a retrospective study.


The study took place in the IVF laboratory of an Infertility Department.


In 349 treatment cycles, clomiphene citrate (CC) and human menopausal gonadotropin (hMG) were used in one group (N =233) and hMG after treatment with a gonadotropin-releasing hormone agonist (GnRHa) in two other groups (long protocol): goserelin (N =73) and buserelin (N =43). Cytogenetic analysis was performed on all unfertilized oocytes in both groups.


Fertilization rates were significantly higher in the GnRHa/hMG group than in the CC/hMG group, but cleavage rates and embryo quality were not different. Of 736 oocytes prepared for cytogenetic analysis, 256 were karyotyped: 172 were found to be euploid and 84 aneuploid. More oocytes were aneuploid in the GnRHa/hMG group than in the CC/hMG group and this difference was statistically different after analysis of the data using a specially designed mathematical model.


If no selection against chromosomally abnormal oocytes takes place at the time of fertilization, more abnormal oocytes are harvested with GnRHa/hMG protocols than with CC/hMG. If, on the other hand, there is a selection against oocytes with some chromosomal imbalance, there is no intrinsic effect of GnRH agonists on the chromosomal complement of the oocyte, and the real aneuploidy frequency in all oocytes, fertilized and unfertilized, is the same in the GnRHa/hMG and in the CC/hMG group.

Key words

in vitro fertilization cytogenetics human oocytes gonadotropin releasing hormone agonists 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Porter RN, Smith W, Craft IL, Abdulwahid NA and Jacobs HS: Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins. Lancet 1984;2:1284–1285Google Scholar
  2. 2.
    Weise HC, Fiedler K, Kato K: Buserelin suppression of endogenous gonadotropin secretion in infertile women with ovarian feedback disorders given human menopausal/human chorionic gonadotropin treatment. Fertil Steril 1988;49:399–403PubMedGoogle Scholar
  3. 3.
    World Health Organization: Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Cambridge, Cambridge University Press, 1987Google Scholar
  4. 4.
    Veeck L, Wortham J, Witmyer J, Sandow B, Acosta A, Garcia J, Jones G, Jones H: Maturation and fertilization of morphologically immature human oocytes in a program of in vitro fertilization. Fertil Steril 1983;39:594–602PubMedGoogle Scholar
  5. 5.
    Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F: Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod 1987;2:705–708PubMedGoogle Scholar
  6. 6.
    Tarkowski AK: An air-drying method for chromosome preparation from mouse eggs. Cytogenetics 1966;5:394–400Google Scholar
  7. 7.
    De Sutter P, Dhont M, Verschraegen-Spae MR, Steyaert H, Corijn W, Leroy J, Vandekerckhove D: Chromosome analysis in human oocytes non fertilized in vitro: A mathematical model for the estimation of the first meiotic non-disjunction frequency. Hum Reprod 1991;6:550–554PubMedGoogle Scholar
  8. 8.
    De Sutter P, Dhont M, Vanluchene E, Vandekerckhove D: Correlations between follicular fluid steroid analysis, maturity and cytogenetic analysis of human oocytes which remained unfertilized after in vitro fertilization. Fertil Steril 1991;55:958–963PubMedGoogle Scholar
  9. 9.
    Maudlin I, Fraser L: The effect of PMSG dose on the incidence of chromosomal anomalies in mouse embryos fertilized in vitro. J Reprod Fertil 1977;50:275–280PubMedGoogle Scholar
  10. 10.
    Boué JG, Boué A: Increased frequency of chromosomal anomalies in abortions after induced ovulation. Lancet 1973;1:679–680Google Scholar
  11. 11.
    Pellestor F, Sele B: Assessment of aneuploidy in the human female by using cytogenetics of IVF failures. Am J Hum Genet 1988;42:274–283PubMedGoogle Scholar
  12. 12.
    Antoine JM, Salat-Baroux J, Alvarez S, Cornet D, Tibi C, Mandelbaum J, Plachot M: Ovarian stimulation using human menopausal gonadotrophins with or without LHRH analogues in a long protocol for in-vitro fertilization: A prospective randomized comparison. Hum Reprod 1990;5:565–569PubMedGoogle Scholar
  13. 13.
    Ferrier A, Rasweiler JJ, Bedford JM, Prey K, Berkeley AS: Evaluation of leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins for in vitro fertilization or gamete intrafallopian transfer. Fertil Steril 1990;54:90–95PubMedGoogle Scholar
  14. 14.
    Maroulis GB, Emery M, Verkauf BS, Saphier A, Bernhisel M, Yeko TR: Prospective randomized study of human menotropin versus a follicular and luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization. Fertil Steril 1991;55:1157–1164PubMedGoogle Scholar
  15. 15.
    van de Helder AB, Helmerhorst FM, Blankhart A, Brand R, Waegemaekers C, Naaktgeboren N: Comparison of ovarian stimulation regimens for in vitro fertilization (IVF) with and without a gonadotropin-releasing hormone (GnRH) agonist: Results of a randomized study. J Vitro Fert Embryo Transfer 1990;7:358–362Google Scholar
  16. 16.
    Cummins J, Breen T, Harrison K, Shaw J, Wilson L, Hennessey J: A formula for scoring human embryo growth rates in in vitro fertilization: Its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J Vitro Fert Embryo Transfer 1986;3:284–295Google Scholar

Copyright information

© Plenum Publishing Corporation 1992

Authors and Affiliations

  • P. De Sutter
    • 1
  • M. Dhont
    • 1
  • D. Vandekerckhove
    • 1
  1. 1.Department of Gynecology and ObstetricsState University of GhentGhentBelgium

Personalised recommendations